While much of the pharma industry has shifted its focus away from antibiotics, Novartis' Sandoz unit is doing just the opposite and is charting next steps in a multi-year manufacturing upgrade in Europe.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,